Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 1. Annual reported cases of notifiable diseases and rates* per 100,000, United States, excluding U.S. Territories and Non-U.S. Residents, 2020
Data from some reporting areas may be incomplete due to the coronavirus disease 2019 (COVID-19) pandemic or due to post-reconciliation data updates that could not be confirmed or included in the final data set. Please see Note #9 and Note #10, respectively.
Disease Case Count Rate
Anthrax 1 0.00
Arboviral diseases
Chikungunya virus disease 37 0.01
Eastern equine encephalitis virus disease
Neuroinvasive 13 0.00
Non-neuroinvasive
Jamestown Canyon virus disease
Neuroinvasive 10 0.00
Non-neuroinvasive 3 0.00
La Crosse virus disease
Neuroinvasive 84 0.03
Non-neuroinvasive 4 0.00
Powassan virus disease
Neuroinvasive 19 0.01
Non-neuroinvasive 1 0.00
St. Louis encephalitis virus disease
Neuroinvasive 14 0.00
Non-neuroinvasive 2 0.00
West Nile virus disease
Neuroinvasive 558 0.17
Non-neuroinvasive 172 0.05
Western equine encephalitis virus disease
Neuroinvasive
Non-neuroinvasive
Babesiosis
Total 1,820 0.64
Confirmed 1,631 0.57
Probable 189 0.07
Botulism
Total 189 0.06
Foodborne 8 0.00
Infant 146 3.91
Other (wound & unspecified) 35 0.01
Brucellosis 87 0.03
Campylobacteriosis 51,764 15.71
Candida auris, clinical  255 0.08
Carbapenemase-producing carbapenem-resistant Enterobacteriaceae 1,848 0.61
Chancroid
Chlamydia trachomatis infection 1,579,837 479.49
Cholera 1 0.00
Coccidioidomycosis 19,220 13.70
Coronavirus Disease 2019 (COVID-19)
Total 21,149,731 6,419.04
Confirmed 19,179,356 5,821.03
Probable § 1,970,375 598.02
Cryptosporidiosis
Total 7,648 2.32
Confirmed 5,861 1.78
Probable 1,787 0.54
Cyclosporiasis 2,689 0.90
Dengue virus infections 
Dengue 441 0.13
Dengue-like illness 9 0.00
Severe dengue
Diphtheria 1 0.00
Ehrlichiosis and Anaplasmosis
Anaplasma phagocytophilum infection 3,637 1.15
Ehrlichia chaffeensis infection 1,178 0.37
Ehrlichia ewingii infection 21 0.01
Undetermined ehrlichiosis/anaplasmosis 50 0.02
Giardiasis 9,453 3.66
Gonorrhea 677,751 205.70
Haemophilus influenzae, invasive disease
All ages, all serotypes 2,996 0.91
Age <5 years
Serotype b 15 0.08
Non-b serotype 76 0.39
Nontypeable 104 0.54
Unknown serotype 121 0.04
Hansen's disease 68 0.02
Hantavirus infection, non-hantavirus pulmonary syndrome ** 2 0.00
Hantavirus pulmonary syndrome 14 0.00
Hemolytic uremic syndrome post-diarrheal 167 0.05
Hepatitis, Viral Disease ††
Hepatitis A 9,946 3.02
Hepatitis B
Acute 2,155 0.66
Perinatal infection 10 0.13
Hepatitis C
Acute 6,025 1.89
Confirmed 4,798 1.50
Probable 1,227 0.38
Perinatal infection 165 1.62
Human immunodeficiency virus diagnoses 25,007 7.59
Influenza-associated pediatric mortality 171 0.23
Invasive pneumococcal disease §§
All ages 11,946 4.86
Confirmed 11,718 4.76
Probable 228 0.09
Age <5 years 561 0.21
Confirmed 536 3.45
Probable 25 0.16
Legionellosis ¶¶ 6,310 1.92
Leptospirosis 51 0.02
Listeriosis ***
Total 780 0.24
Confirmed 754 0.23
Probable 26 0.01
Lyme disease
Total 18,000 5.49
Confirmed 12,123 3.70
Probable 5,877 1.79
Malaria 603 0.18
Measles †††
Total 12 0.00
Indigenous 6 0.00
Imported 6 0.00
Meningococcal disease
All serogroups 242 0.07
Serogroups ACWY 80 0.02
Serogroup B 40 0.01
Other serogroups 16 0.00
Unknown serogroup 106 0.03
Mumps 694 0.21
Novel Influenza A virus infections
Pertussis 6,124 1.86
Plague §§§ 9 0.00
Poliomyelitis, paralytic
Poliovirus infection, nonparalytic
Psittacosis 8 0.00
Q fever
Total 120 0.04
Acute 90 0.03
Chronic 30 0.01
Rabies
Animal 4,457 1.35
Human
Rubella 6 0.00
Rubella, congenital syndrome
Salmonella Paratyphi infection ¶¶¶ 75 0.02
Salmonella Typhi infection **** 182 0.06
Salmonellosis (excluding S. Typhi infection and S. Paratyphi infection) †††† 45,442 13.79
Severe acute respiratory syndrome-associated coronavirus disease
Shiga toxin-producing Escherichia coli (STEC) 9,922 3.01
Shigellosis 9,108 2.76
Smallpox
Spotted fever rickettsiosis
Total 1,175 0.36
Confirmed 64 0.02
Probable 1,111 0.34
Streptococcal toxic shock syndrome 224 0.11
Syphilis
Total, all stages §§§§ 133,933 40.65
Congenital ¶¶¶¶ 2,148 55.88
Primary and secondary 41,654 12.64
Tetanus 17 0.01
Toxic shock syndrome (other than Streptococcal) 24 0.01
Trichinellosis
Tuberculosis 7,174 2.18
Tularemia 150 0.05
Vancomycin-intermediate Staphylococcus aureus 45 0.02
Vancomycin-resistant Staphylococcus aureus ***** 1 0.00
Varicella morbidity 2,927 1.05
Varicella mortality 1 0.00
Vibriosis
Total 1,852 0.57
Confirmed 1,133 0.35
Probable 719 0.22
Viral hemorrhagic fevers
Crimean-Congo hemorrhagic fever virus
Ebola virus
Guanarito virus
Junin virus
Lassa virus
Lujo virus
Machupo virus
Marburg virus
Sabia virus
Yellow fever
Zika virus
Zika virus disease, congenital †††††
Zika virus disease, non-congenital 4 0.00
Zika virus infection, congenital †††††
Zika virus infection, non-congenital 19 0.01
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • * For population data, see Table 8. Also see Notes #3 and #7.
  • Candida auris colonization/screening cases are not included in this table. These data are available on the Mycotic Diseases Branch's Tracking Candida auris page (https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html)
  • § Please see Note #11.
  • ¶ Counts include confirmed and probable dengue cases.
  • ** Case counts may include Old World hantavirus infections, such as Seoul virus.
  • †† Chronic hepatitis B and chronic hepatitis C data are not included in NNDSS tables but reported case counts are included in the annual Viral Hepatitis Surveillance Report, 2020, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm.
  • §§ Counts include drug resistant and susceptible cases of Invasive Pneumococcal Disease. This condition was previously named Streptococcus pneumoniae invasive disease and cases were reported to CDC using different event codes to specify whether the cases were drug resistant or in a defined age group, such as <5 years.
  • ¶¶ In 2020, the CSTE case definition changed such that cases diagnosed by PCR were classified as confirmed, whereas previously those cases were classified as suspect and did not meet the publication/print criteria.
  • *** Before 2019, probable cases were not reported, and cases in neonates ≤60 days of age were counted as one case in a mother-infant pair. Beginning in 2019, confirmed and probable cases are being reported, and maternal and neonatal cases are being counted separately.
  • ††† Measles is considered imported if the disease was acquired outside of the United States and is considered indigenous if the disease was acquired anywhere within the United States or it is not known where the disease was acquired.
  • §§§ Beginning in 2020, confirmed and probable plague cases are being combined and published. In 2019, only confirmed plague cases were published.
  • ¶¶¶ Beginning in January 2019, cases began to be reported as Salmonella Paratyphi infection. In 2018, cases were reported as paratyphoid fever. Prior to 2018, cases of paratyphoid fever were considered salmonellosis.
  • **** Beginning in January 2019, cases began to be reported as Salmonella Typhi infection. In previous years, cases were reported as typhoid fever.
  • †††† Beginning in January 2019, cases began to be reported as salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection). In 2018, cases were reported as salmonellosis (excluding paratyphoid fever and typhoid fever). Prior to 2018, cases of paratyphoid fever were considered salmonellosis.
  • §§§§ Includes the following categories: primary; secondary; early non-primary non-secondary (includes cases previously reported as early latent); unknown duration or late (includes cases previously reported as late latent syphilis and cases previously reported as late syphilis with clinical manifestations) and congenital syphilis.
  • ¶¶¶¶ Congenital syphilis cases are usually assigned to the mother's state of residence at the time of delivery. Data for congenital syphilis are aggregated by the infant's year of birth.
  • ***** Vancomycin-resistant Staphylococcus aureus cases reported in this table may not have been verified by CDC. CDC verified 0 vancomycin-resistant Staphylococcus aureus cases in 2020.
  • ††††† Data reported to ArboNET using the national surveillance case definition for congenital Zika virus infection (CSTE Position Statement 16-ID-01).